Position in REGN
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$1,148,143
+$395,570 QoQ
Shares Held
1,486
+52.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ROTHSCHILD INVESTMENT LLC holds $5,484,521 across 220 Biotechnology names. REGN ranks #1 (20.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
1,486 | $1,148,143 | |
| 2 | TECH |
BIO-TECHNE Corp
|
18,736 | $979,143 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
7,865 | $444,293 | |
| 4 | INCY |
Incyte Corp
|
4,540 | $427,304 | |
| 5 | CGEN |
Compugen Ltd
|
140,600 | $299,478 | |
| 6 | EXEL |
Exelixis, Inc.
|
6,941 | $297,699 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
437 | $195,137 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
883 | $166,931 |
All Filings in REGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,148,143 | 1,486 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $752,573 | 975 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $342,422 | 609 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $211,575 | 403 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $253,692 | 400 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $324,110 | 455 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $567,669 | 540 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $626,413 | 596 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $493,757 | 513 | Shares | Sole | 2024-07-31 | |
| 2023-12-31 | $440,023 | 501 | Shares | Sole | 2024-07-31 | |
| No filing history on record for this holder in this stock. | ||||||